ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Foti Receives Del Duca Award; Wake Forest To Hire 60 Faculty.

February 11, 2000

DCT Board Approves Drug Development Recompetition

November 30, 1990

Centers Settle Into New Home, Face Old Problem; Five May Lose Grants, No Reprogramming Seen

November 17, 1989

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

NCI Staff Finishes Center Program Study, Submits Recommendations

February 25, 1977

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982